THR Technologies: The Leading Edge of Nutraceutical Cannabis.
THR Technologies is a division of Quicksilver Scientific, the leader in nutraceutical delivery systems. THR has developed a turnkey business model and production system for manufacturers of cannabis-infused products who are looking for an innovative edge in the crowded “edibles” market. With this model, licensed manufacturers can access the world-class Quicksilver Scientific technology and produce rapid-uptake sublingual nano serums to market in medical dispensaries and adult-use retail outlets.
Sublingual nano serums bring the power of intravenous therapy into convenient oral delivery. The therapeutic power of cannabis is enhanced through nano encapsulation into smaller, more stable single-layer spheres known as “liposomes.” Liposomes are microscopic spheres made of phospholipids, which are the building blocks of cell membranes. By encapsulating compounds such as cannabinoids in phospholipids, manufacturers can create fast-acting sublingual products that bypass the digestive processes which limit absorption. Well-engineered liposomes demonstrate the ability to cross the blood-brain barrier and enhance the lymphatic circulation of therapeutic compounds.
Through license agreement with THR, infused product manufacturers can differentiate from competitors by offering a discreet/smoke-free diabetic-friendly alternative to flower, concentrates, vapes and gummies. Rapid uptake sublingual nano serums are also an outstanding alternative to slow-acting tinctures, which often produce disappointing results.